Page last updated: 2024-11-05

ticlopidine and Pulmonary Eosinophilia

ticlopidine has been researched along with Pulmonary Eosinophilia in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizuno, Y1
Shimizu, H1
Yamashita, M1
Horie, Y1
Mizō, A1

Other Studies

1 other study available for ticlopidine and Pulmonary Eosinophilia

ArticleYear
[A case of clopidogrel-induced eosinophilic pneumonia].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2011, Volume: 49, Issue:11

    Topics: Aged, 80 and over; Clopidogrel; Humans; Male; Platelet Aggregation Inhibitors; Pulmonary Eosinophili

2011